Работы, цитирующие эту работу

Работ: 5

Работа: Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   СтатьяCAR-T cell therapy researchClinical & Translational Oncology2026Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.article.000172

2. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

   Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7

   СтатьяCAR-T cell therapy researchClinical & Translational Oncology2026Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.article.000259

3. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   СтатьяCAR-T cell therapy researchHeliyon2024Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.102962

4. An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies

   Xin Xin, Chunhui Fan, Ran Sheng +7

   СтатьяMultiple Myeloma Research and TreatmentsClinical and Experimental Medicine2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.000299

5. Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders

   Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Ghaleb Oriquat, Sokhib Saidov +5

   СтатьяCAR-T cell therapy researchClinica Chimica Acta2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.017391